CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

UK's midcap index at record high ahead of Bank of England rate call

By Reuters News

Nov 5 (Reuters) - Britain's midcap FTSE 250 index hit a record high and the blue-chip FTSE 100 rose to a near three-month peak on Thursday, boosted by bank stocks ahead of the Bank of England's policy decision.

The FTSE 100 index .FTSE rose 0.5% to 10,888.64 points by 1034 GMT, while the FTSE 250 .FTMC climbed 0.6% to its all-time high.

  • The BoE is widely expected to deliver a 25-basis-point hike on Thursday, its first rate increase in three years, as inflation pressures linked to the US-Israeli war on Iran mount

  • Major central banks such as the US Federal Reserve and the European Central Bank have already raised rates, and more hikes are priced in

  • Britain's inflation held at 3.5% in September, well above the BoE's target of 2%, data released last month showed

  • After rallying on Wednesday, banking stocks .FTNMX301010 extended gains, rising 1.3% to an over-one-week high. HSBC HSBA.L was the biggest boost with a 1.2% jump

  • Precious metal miners .FTNMX551030 rose 5%, boosted by gold prices climbing to a two-week high, after marking their biggest one-day jump in three months in the last session GOL/

  • But pharma .FTNMX201030 and energy .FTNMX601010 sectors declined 0.3% and 0.5% respectively

  • Telecom firm BT Group BT.L gained 3.5% after beating second-quarter revenue estimates; the broader sector .FTNMX151020 rose 1.2%

  • Defence contractor BAE Systems BAES.L slid 4.1% to the bottom of the FTSE 100. The loss builds on Wednesday's 4% fall after the Democratic sweep in the US midterm elections raised concerns of a tighter military budget

  • Hikma Pharmaceuticals HIK.L bottomed the FTSE 250 with a 6% drop after the drugmaker lowered the higher end of its annual profit forecast range

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.